Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Other Non Operating Income (2022 - 2025)

Historic Other Non Operating Income for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to $31550.0.

  • 60 Degrees Pharmaceuticals' Other Non Operating Income rose 8979.73% to $31550.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $109044.0, marking a year-over-year increase of 6188.72%. This contributed to the annual value of $101464.0 for FY2024, which is 9811.38% down from last year.
  • Per 60 Degrees Pharmaceuticals' latest filing, its Other Non Operating Income stood at $31550.0 for Q3 2025, which was up 8979.73% from $13066.0 recorded in Q2 2025.
  • Over the past 5 years, 60 Degrees Pharmaceuticals' Other Non Operating Income peaked at $6.1 million during Q3 2023, and registered a low of -$1.1 million during Q2 2023.
  • For the 4-year period, 60 Degrees Pharmaceuticals' Other Non Operating Income averaged around $375394.2, with its median value being $25003.0 (2024).
  • As far as peak fluctuations go, 60 Degrees Pharmaceuticals' Other Non Operating Income soared by 2723965.77% in 2023, and later crashed by 9972.77% in 2024.
  • Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Other Non Operating Income stood at $150493.0 in 2022, then surged by 3956.71% to $6.1 million in 2023, then crashed by 99.44% to $34106.0 in 2024, then decreased by 7.49% to $31550.0 in 2025.
  • Its Other Non Operating Income stands at $31550.0 for Q3 2025, versus $13066.0 for Q2 2025 and $30322.0 for Q1 2025.